Furthermore, comprehensive kinase analysis highlighted AURKB as a pivotal kinase that orchestrates mitosis, which causes DA resistance, suggesting that AURKB could serve as a potential sensor for DA regimen in de novo AML patients, as well as DAV regimen in AML patients exhibited resistance to DA regimen caused by AURKB activation. This evidence concerns the gene AURKB and acute myeloid leukemia.